1. Down regulation of miR-30a-5p and miR-182–5p in gastric cancer: Clinical impact and survival analysis
- Author
-
Shimaa E. Soliman, Naglaa S. Elabd, Salah M. EL-Kousy, and Mohamed F. Awad
- Subjects
Gastric cancer ,miR-30a-5p ,miR-182–5p ,RT-PCR ,Biology (General) ,QH301-705.5 ,Biochemistry ,QD415-436 - Abstract
Background and aim: Gastric Cancer (GC) is a leading cause of morbidity and mortality worldwide, particularly in developing nations, only a few suitable gastric cancer serum biomarkers with acceptable sensitivity and specificity exist. This work aims to highlight and uncover miR-30a-5p and miR-182–5p′s diagnostic roles regarding gastric cancer and their roles in predicting prognosis. Methods: 148 patients participated in this study. Groups I, II, and III had 47 patients with GC, 54 patients with benign gastric lesions, and 47 apparently healthy subjects of coincided age and gender as controls, respectively. All participants were clinically evaluated and subjected to CBC, serum CEA, and CA19-9 by ELISA, and real-time PCR tests of miR-30a-5p and miR-182–5p. Results: MiR30a-5p and miR-182–5p were down regulated in gastric cancer patients in Group I more than Groups II and III (P
- Published
- 2021
- Full Text
- View/download PDF